Fundación Pública Andaluza Para La Gestión De La Investigación En Sevilla
Clinical trials sponsored by Fundación Pública Andaluza Para La Gestión De La Investigación En Sevilla, explained in plain language.
-
Can a Salt-Marsh plant supplement beat high cholesterol without drugs?
Disease control Not yet recruitingThis study tests a dietary supplement made from salicornia (a salt-marsh plant) and B vitamins in 250 adults aged 40-65 with newly diagnosed high cholesterol who do not yet need medication. Participants will either take the supplement or follow standard care, and researchers will…
Phase: NA • Sponsor: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla • Aim: Disease control
Last updated May 26, 2026 05:03 UTC
-
Could a common blood thinner boost antibiotics against deadly staph infections?
Disease control Not yet recruitingThis study tests whether adding clopidogrel, a drug usually used to prevent blood clots, to standard antibiotics can improve outcomes for people with a serious Staphylococcus aureus bloodstream infection. About 230 hospitalized adults will be randomly assigned to receive either s…
Phase: PHASE2 • Sponsor: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla • Aim: Disease control
Last updated May 18, 2026 12:09 UTC
-
AI-Powered therapy for teens shows promise in new trial
Symptom relief Not yet recruitingThis study tests a program called AGENCIA, which uses digital tools and AI to help teens aged 12-18 with emotional or behavioral issues like irritability or impulsivity. Participants are split into three groups: a self-guided online version, an in-person version with a digital as…
Phase: NA • Sponsor: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla • Aim: Symptom relief
Last updated May 26, 2026 04:37 UTC
-
New hope for seniors with stubborn depression: esketamine spray vs aripiprazole pill
Symptom relief Not yet recruitingThis study tests whether esketamine nasal spray works better than aripiprazole pills for older adults (60-74 years) whose depression hasn't improved with standard antidepressants. Both treatments are added to the patient's current antidepressant. The main goal is to see if sympto…
Phase: PHASE3 • Sponsor: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla • Aim: Symptom relief
Last updated May 11, 2026 20:49 UTC
-
New study aims to predict superbug infections in blood cancer patients
Knowledge-focused Not yet recruitingThis study watches 535 blood cancer patients to learn why some get serious infections from drug-resistant bacteria. Researchers will collect swabs and health data to build a prediction score. The goal is to better identify who is at highest risk, but no new treatment is tested.
Sponsor: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla • Aim: Knowledge-focused
Last updated May 26, 2026 05:11 UTC